MEDIPOST CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,110 KRW | 0.00% |
|
+1.43% | -12.87% |
| Sales 2022 | 64.2B 47.12M 64.84M | Sales 2023 | 68.64B 50.38M 69.33M | Capitalization | 278B 204M 281M |
|---|---|---|---|---|---|
| Net income 2022 | 3.07B 2.25M 3.1M | Net income 2023 | 5.84B 4.29M 5.9M | EV / Sales 2022 | 2.59 x |
| Net cash position 2022 | 74.1B 54.39M 74.84M | Net cash position 2023 | 148B 109M 149M | EV / Sales 2023 | 1.9 x |
| P/E ratio 2022 |
78.4
x | P/E ratio 2023 |
35.3
x | Employees | 289 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 60.13% |
More Fundamentals
* Assessed data
More news
| 1 week | +1.43% | ||
| Current month | +0.28% | ||
| 1 month | -0.42% | ||
| 3 months | -2.47% | ||
| 6 months | -4.18% | ||
| Current year | -12.87% |
1 week
6 980.00
7 230.00
1 month
6 590.007 230.00
Current year
6 590.008 920.00
1 year
6 590.0015 700.00
3 years
6 590.0034 450.00
5 years
6 590.0045 300.00
10 years
6 590.0089 950.00
| Managers | Title | Age | Since |
|---|---|---|---|
Won-Il Oh
CEO | Chief Executive Officer | 61 | 00-06-25 |
Soo-Jin Choi
CTO | Chief Tech/Sci/R&D Officer | 52 | 02-01-11 |
Jang-Won Lee
BRD | Director/Board Member | 58 | 10-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Won-Il Oh
CEO | Chief Executive Officer | 61 | 00-06-25 |
Jae-Wook Oh
BRD | Director/Board Member | 62 | 12-03-29 |
Hyun-Ki Min
BRD | Director/Board Member | 59 | 12-03-29 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 7,110 | 0.00% | 46,686 |
| 24-05-02 | 7,110 | +0.28% | 43,439 |
| 24-04-30 | 7,090 | +0.28% | 43,148 |
| 24-04-29 | 7,070 | +0.86% | 28,987 |
| 24-04-26 | 7,010 | -0.85% | 28,542 |
End-of-day quote Korea S.E., May 02, 2024
More quotes
MEDIPOST Co., Ltd. is a Korea-based company engaged in the biotechnology business. The Company mainly operates cord blood banks. Its cord blood banks consist of public cord blood bank, which provides resource to anyone who may need to undergo hematopoietic stem cell transplantation (HSCT) as a result of blood-related diseases, such as leukemia or aplastic anemia, as well as family cord blood bank, which provides services for storing newbornâs cord blood exclusively for familyâs use. It also involves in the provision of stem cell drugs, which are used for recovery of knee articular cartilage and others, distribution of healthcare food and natural cosmetics, as well as provision of healthcare services.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -12.87% | 179M | |
| +25.69% | 47.86B | |
| +46.90% | 41.42B | |
| -3.46% | 40.66B | |
| -6.20% | 28.92B | |
| +9.17% | 25.55B | |
| -20.42% | 19.27B | |
| +28.07% | 12.14B | |
| +0.17% | 12.15B | |
| -1.24% | 11.99B |
- Stock Market
- Equities
- A078160 Stock
